Decreased ADAMTS13 and increased VWF levels are relevant in TTP, which clinically manifests itself as thrombocytopenia, micro-angiopathic hemolytic anemia, fever, neurological symptoms and renal insufficiency due to the formation of microthrombi [5]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.